Navigation Links
LifeVantage to Present at Rodman & Renshaw Annual Global Investment Conference
Date:8/31/2011

SALT LAKE CITY, Aug. 31, 2011 /PRNewswire/ -- LifeVantage Corporation (OTCBB: LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today that Douglas C. Robinson, the Company's President and Chief Executive Officer, and Dr. Joe McCord, the Company's Chief Science Officer, will be presenting at the Rodman & Renshaw Annual Global Investment Conference, to be held on September 11-13, 2011, at the Waldorf Astoria in New York.

(Logo: http://photos.prnewswire.com/prnh/20090930/LIFEVANTAGELOGO)  

The LifeVantage investor presentation is scheduled for Tuesday, September 13, 2011, at 9:10 am Eastern Time.  The presentation will be webcast live and archived at www.LifeVantage.com. Visitors to the website should select the "Investor Info" link to access the webcast.

At the Rodman & Renshaw Annual Global Investment Conference, more than 520 public & private companies from around the world are registered to present in front of an audience of over 4,000 attendees. The conference will feature tracks devoted to Healthcare, China, Metals & Mining, Energy, Technology, Cleantech, Financial Services, Israel and Growth/Special Situations. Al Gore, 45th Vice President of the United States, will open the Conference as the Keynote Speaker on Monday, September 12, 2011. Additional highlights of the conference include a speech by Henry Kissinger, 56th United States Secretary of State, who will address the audience as a special Guest Speaker on Tuesday, September 13, 2011. Dr. Kissinger's speech will be followed by corporate presentations, Q & A sessions, investor one-on-one meetings and daily networking opportunities.

About LifeVantage Corporation

LifeVantage, (OTCBB: LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, is a science based nutraceutical company. LifeVantage is dedicated to visionary science that promises to transform wellness and anti-aging internally and externally with supplements that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 and currently has operations in Salt Lake City, Utah and San Diego, CA. For more information, visit www.LifeVantage.com.

Investor Relations Contact:
Cindy England (801) 432-9036
Director of Investor Relations
-or-
John Mills (310) 954-1105
Senior Managing Director, ICR, LLC


'/>"/>
SOURCE LifeVantage Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. LifeVantage Announces Preliminary Third Quarter 2011 Revenue
2. LifeVantage Announces Settlement of Zrii Litigation
3. LifeVantage Announces Unaudited First Quarter Fiscal 2010 Financial and Operating Results
4. LifeVantage Announces Preliminary Unaudited First Quarter Revenue
5. LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results
6. Echo Therapeutics to Present at the Stifel Nicolaus Healthcare Conference 2011
7. BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences
8. Elbit Imaging Announces Availability of Investor Relations Presentation - Analysis Sources and Uses
9. Inovio Pharmaceuticals to Present at Investor Conferences
10. Watson to Present at the 2011 Morgan Stanley Global Healthcare Conference
11. Luminex Corporation to Present at Upcoming Investment Conferences In September
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017  Rosen Law Firm, a ... a class action lawsuit on behalf of purchasers of ... ) pursuant and/or traceable to Kitov,s initial public offering ... on the open market from November 20, 2015 through ... The lawsuit seeks to recover damages for Kitov investors ...
(Date:3/28/2017)... , March 29, 2017 ... Siteless CRO platform, announced today study results ... Managed Care Pharmacy, #AMCP2017, Managed Care and Specialty Pharmacy ... . Data in both posters demonstrated that pharmacist-led ... and protocol adherence. These factors are crucial to generating ...
(Date:3/28/2017)... , March 28, 2017 Emosis SAS, ... new business entity, Emosis Ltd, headquartered in Tel Aviv ... novel assays complementing the mother company existing technology platform and test ... sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. Emosis ...
Breaking Medicine Technology:
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is the first technology to directly address the resolution to globally reduce the ... is a patented compound of FDA and TTB approved ingredients that when infused ...
(Date:3/28/2017)... ... 29, 2017 , ... The Thyroid Secret is a specialized ... The program was recently launched on March 1, and Dr. Wentz discussed varied ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... dedicated to advancing the science and clinical practice of radiosurgery, announced today ... Registry, a multi-institutional, observational registry established to standardize data collection from patients ...
(Date:3/28/2017)... DC (PRWEB) , ... March 28, 2017 , ... WHO: ... Dr. Toni Bark , WHAT: , Medical doctors and PhD scientists will speak to ... written to President Trump in support of an independent vaccine safety commission. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Paul Yost, will begin serving as new board chair for Orange County health ... will serve the remainder of soon-to-be former chair Mark Refowitz’s term, which runs ...
Breaking Medicine News(10 mins):